InterCare DX, Inc.
ICCO
Other OTC0.00
USD
- -
- -
CIK
0001103310
ISIN
US45845C1071
CUSIP
45845C107
Return %
Stock
S&P500
1Y
-97.22
18.02
3Y
-99.64
64.11
5Y
-99.60
72.15
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Anthony C. Dike
- Sector
- Technology
- Industry
- Software - Application
- Address
- 4477 West 118th Street Torrance CA United States of America 90250
- IPO Date
- Jul 24, 2009
- CIK
- 0001103310
- Website
- intercare.com
- Similar Companies
- Business
- InterCare DX, Inc. (Ticker: ICCO) is a medical technology company primarily engaged in the development, manufacture, and commercialization of diagnostic solutions and healthcare testing products. The company’s core offerings include a range of diagnostic test kits, medical devices, and laboratory testing services focused on infectious diseases, molecular diagnostics, and general health diagnostics. InterCare operates across multiple geographic regions, primarily in the United States, targeting healthcare providers, hospitals, clinical laboratories, and diagnostic centers. InterCare DX’s product portfolio includes molecular diagnostic kits for detecting viral, bacterial, and other pathogenic infections; point-of-care testing devices; specialty diagnostic reagents; and digital health data management solutions. The company develops and markets these products under its own brand while collaborating with partners to expand technological capabilities and market reach. In terms of recent major changes, InterCare DX has been actively pursuing strategic partnerships and alliances to enhance its technological platforms and broaden its service offerings in the diagnostic space. Over the past 1-2 years, the company has launched new advanced diagnostic test products, expanded its molecular testing capabilities, and initiated operational enhancements to support scalability and efficiency. Additionally, it has undertaken funding rounds to support research and development initiatives and market expansion, positioning itself for growth within the competitive medical diagnostics industry. Founded in 2010, InterCare DX, Inc. is headquartered in Boston, Massachusetts. The company operates independently with a focus on cutting-edge diagnostic innovation and improving patient outcomes through reliable and rapid testing technologies. Its business segments include molecular diagnostics, infectious disease testing, and healthcare data analytics, serving healthcare professionals and institutions globally.